Iparomlimab (anti-PDCD1)K14482 · CAS 2417649-33-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
生化试剂
共170,175件商品Azintuxizumab (anti-SLAMF7)K14483 · CAS 1826819-57-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Losatuxizumab (anti-EGFR)K14484 · CAS 1801544-27-3
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Oportuzumab (anti-EpCAM)K14485
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
NTX-1088 (anti-PVR)K14486
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Naptumomab (anti-TPBG)K14487 · CAS 676258-98-3
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
FA19-1 (anti-DCBLD2)K14488
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Favezelimab (anti-LAG3)K14489 · CAS 2231068-83-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Lodelcizumab (anti-PCSK9)K14490 · CAS 1355338-54-3
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Letaplimab (anti-CD47)K14491 · CAS 2283356-07-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Amlitelimab (anti-TNFSF4)K14492 · CAS 2378692-15-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
CD200/OX2 Rat mAb (AF647)K14493
已验证, Ex:650nm, Em:668nm, 0.5 mg/mL
CD200/OX2 Rat mAb (Biotin)K14494
ExactAb™, 已验证, 0.5 mg/mL
CD200/OX2 Rat mAb (FITC)K14495
已验证, Ex:498nm, Em:517nm, 0.5 mg/mL
CD200/OX2 Rat mAb (PE)K14496
已验证, Ex:565nm, Em:575nm, 0.5 mg/mL
CD200/OX2 Rat mAb (APC)K14497
已验证, Ex:650nm, Em:660nm, 0.5 mg/mL
Transferrin Receptor/CD71 Rat mAb (Biotin)K14498
ExactAb™, 已验证, 0.5 mg/mL
Transferrin Receptor/CD71 Rat mAb (FITC)K14499
已验证, Ex:498nm, Em:517nm, 0.5 mg/mL
Transferrin Receptor/CD71 Rat mAb (PE)K14500
已验证, Ex:565nm, Em:575nm, 0.5 mg/mL
Transferrin Receptor/CD71 Rat mAb (APC)K14501
已验证, Ex:650nm, Em:660nm, 0.5 mg/mL
CD8 alpha Rat mAb (Biotin)K14502
已验证, 0.5 mg/mL
CD8 alpha Rat mAb (FITC)K14503
已验证, Ex:498nm, Em:517nm, 0.5 mg/mL
CD8 alpha Rat mAb (PE)K14504
已验证, Ex:565nm, Em:575nm, 0.5 mg/mL
CD8 alpha Rat mAb (AF647)K14505
已验证, Ex:650nm, Em:668nm, 0.5 mg/mL
第 187 / 7091 页